PBIO News and Press, Pressure BioSciences Inc From 09/21/23

Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, can...

Further Innovations Announced, with All Systems Go for Fulfilling Current and Future Orders; UltraShear is No Longer Just the Name of a Patented, Revolutionary, One-of-a Kind Nanoemulsification Process, It is Now a Revenue-Generating Machine. SOUTH EASTON, MA / ACCESSWIRE / September 21, 2023...

Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmeceuticals, food and beverage, and other industries, is making ...

Patented BaroFold Platform is Critical Enabler for Biopharma Manufacturing and Quality Assurance; Company Believes Future BaroFold Equipment and Recurring Utilization/Support Fees Should Exceed $100 Million in Annual Revenue SOUTH EASTON, MA / ACCESSWIRE / September 8, 2023 / Press...

Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, can...

Additional Five Customers Committed to Distributing PBIO's Best-in-Class UltraShear Nano-CBD, Representing Nearly 350 Retailers and Over $200K Incremental 2023 Sales SOUTH EASTON, MA / ACCESSWIRE / August 30, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global ...

2023-08-22 13:24:31 ET Pressure BioSciences press release ( OTC:PBIO ): Q2 GAAP EPS of -$0.57. Revenue of $0.51M (+2.0% Y/Y). For further details see: Pressure BioSciences GAAP EPS of -$0.57, revenue of $0.51M

Investor Call Scheduled for Tuesday, August 22, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / August 22, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and spec...

Pressure BioSciences (OTCQB: PBIO) today announced that its CEO and President Richard T. Schumacher and Director of Marketing and Sales John B. Hollister are the featured speakers at an online webinar scheduled for 11 a.m. ET on Thursday, Aug. 17, 2023. The webinar will showcase an overview of...

Webinar Scheduled for 11:00AM ET on Thursday, August 17; Nearly 500 Registrants to Date. SOUTH EASTON, MA / ACCESSWIRE / August 17, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based e...